Liminatus Pharma, Inc. (LIMN)

Name: Liminatus Pharma, Inc. (LIMN) — annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001971387

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 8-K · 2026-08-18

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended	2025-12-31	2024-12-31	2023-12-31
Operating Income	-$2.97M	-$3.33M	—
Net Income	-$10.21M	-$3.55M	—
EPS (Diluted)	$-0.43	$-0.20	—
Total Assets	$512.8K	$5.41M	—
Total Liabilities	$10.33M	$24.75M	—
Shareholders' Equity	-$9.81M	-$19.34M	-$15.79M
Operating Cash Flow	-$9.96M	-$1.45M	—
Capital Expenditures	$13.1K	—	—
Shares Outstanding	27.06M	17.50M	—
Weighted Average Diluted Shares	23.75M	17.50M	—
EPS (Basic)	$-0.43	$-0.20	—